Sudarshan Pharma Industries Fair Value
Fair Value Analysis Export
P/E Based Valuation
P/B Based Valuation
Asset-Based Valuation
Benjamin Graham Number
SUDARSHAN Fair Value Analysis — Data Sources & Coverage
Sudarshan Pharma Industries financial data sources, valuation methods applied and sector benchmarks used — 2025 financial year. Examine Sudarshan Pharma Industries quarterly financials for recent quarterly revenue, profit and EPS trends.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is from the previous year (2025).
SUDARSHAN vs Chemicals Sector Peers — P/E, P/B & Market Cap
Sudarshan Pharma Industries P/E ratio, P/B ratio and market capitalisation vs Chemicals sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Polychem | POLYCHEM | - | 1.8 | ₹86 |
| Kanchi Karpooram | KANCHI | 29.19 | 0.7 | ₹148 |
| Blue Pearl Agriventures | BPAGRI | 2564.0 | 25.33 | ₹1,622 |
| Omkar Pharmachem | OMKARPH | 157.39 | 3.03 | ₹29 |
| Beezaasan Explotech | BEEZAASAN | 20.83 | 1.94 | ₹309 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.